Literature DB >> 4203161

Cumulative effects of pulsed exposures of mycobacterium tuberculosis to isoniazid.

A M Awaness, D A Mitchison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4203161     DOI: 10.1016/0041-3879(73)90035-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  7 in total

Review 1.  Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Proc R Soc Med       Date:  1977-01

Review 2.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

3.  Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid.

Authors:  Ashwini G Bhat; Rohit Vashisht; Nagasuma Chandra
Journal:  Syst Synth Biol       Date:  2011-02-26

4.  Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.

Authors:  Ming Zhang; Si-Yang Li; Ian M Rosenthal; Deepak V Almeida; Zahoor Ahmad; Paul J Converse; Charles A Peloquin; Eric L Nuermberger; Jacques H Grosset
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

5.  A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Authors:  Kamunkhwala Gausi; Elisa H Ignatius; Xin Sun; Soyeon Kim; Laura Moran; Lubbe Wiesner; Florian von Groote-Bidlingmaier; Richard Hafner; Kathleen Donahue; Naadira Vanker; Susan L Rosenkranz; Susan Swindells; Andreas H Diacon; Eric L Nuermberger; Kelly E Dooley; Paolo Denti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 21.405

6.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

Review 7.  Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure.

Authors:  Vincent Launay-Vacher; Hassane Izzedine; Gilbert Deray
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.